Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.
about
Immunological Landscape and Clinical Management of Rectal CancerNew Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal CancerStereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancerRole of tumor size in the pre-operative management of rectal cancer patients.Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer.Cancer stem cell-related factors are associated with the efficacy of pre-operative chemoradiotherapy for locally advanced rectal cancer.Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheresThe status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapyHigh Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction.Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2.Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.Locally advanced rectal cancer: a comparison of management strategies.EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection.High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients.Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours.The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.Molecular Biology: Are We Getting Any Closer to Providing Clinically Useful Information?MRI In rectal cancer: Correlations between MRI features and molecular markers Ki-67, HIF-1α, and VEGF.beta-Tryptase up-regulates vascular endothelial growth factor expression via proteinase-activated receptor-2 and mitogen-activated protein kinase pathways in bone marrow stromal cells in acute myeloid leukemia.Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.Histogram analysis of ADC in rectal cancer: associations with different histopathological findings including expression of EGFR, Hif1-alpha, VEGF, p53, PD1, and KI 67. A preliminary study.The role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancerStereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review
P2860
Q26768531-A72AB190-DF8F-444C-8EDD-BE402C1DE85DQ26786311-82B40849-8817-4592-85F1-E5D22DF42E64Q26866335-A36C3BE0-A41A-4865-A0F7-D5C42DB9C1A0Q33605399-7ADB63B0-FE72-4462-B248-EF05C620205BQ33997798-9EECF288-9917-4221-840A-65A63135635DQ34438092-BB3B8EF6-AE79-4A57-9AE7-0762B03B0775Q36230733-0A4F560E-48FE-412F-9599-5D42D646A994Q36697911-59EFE3C9-2292-4D51-94AA-528121966E7AQ37015715-E77077AF-34CD-4754-B2E7-8730212114DFQ37106318-D6CD7B2D-55D3-443D-A389-4A490D4C8131Q37269734-146E0D2A-A226-46B3-982A-E6D79015C7DDQ37598888-E0C1D031-D5D5-42A8-9EBE-54B9D157544DQ37709253-CA3FCCEB-9AE8-4C04-923B-8CFC4C9C35B5Q37743143-3B49C549-CD2E-4911-8277-49F5554A3427Q37895253-749925C1-30E5-437C-A10E-0BD4D576A585Q38552978-A08635C5-C211-4A27-8EE5-4EB7351E0C22Q43640344-FC5F4499-93B0-4166-A067-823B74076A73Q44877290-EC3ECD0A-BA42-4A24-A35E-0AC836CE3949Q46037079-3389B516-E29F-4F7C-ACA1-930D6A9DA05FQ49564034-DF071410-3E62-4BCF-9D86-552112BFF61CQ50703877-8A8EE898-88E8-44E0-AAB4-12DDEF468EE3Q54422518-5D7D06D5-2D40-4886-90FF-4B7D4433E579Q54655477-F5CB2AC8-E708-4F79-8AF3-A0F6321F6FFEQ55260351-B26B8C53-3BAC-43AD-B56F-AC9ABD972DBFQ57088778-4E2FCF7E-5DAF-429E-BF78-C9E4AFA3A3A7Q57826812-C03752EA-EE6F-4586-B497-4E472B564EED
P2860
Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Combined analysis of VEGF and ...... ith preoperative radiotherapy.
@ast
Combined analysis of VEGF and ...... ith preoperative radiotherapy.
@en
type
label
Combined analysis of VEGF and ...... ith preoperative radiotherapy.
@ast
Combined analysis of VEGF and ...... ith preoperative radiotherapy.
@en
prefLabel
Combined analysis of VEGF and ...... ith preoperative radiotherapy.
@ast
Combined analysis of VEGF and ...... ith preoperative radiotherapy.
@en
P2093
P2860
P356
P1476
Combined analysis of VEGF and ...... ith preoperative radiotherapy.
@en
P2093
C C Compton
R P Michel
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604172
P407
P577
2008-01-08T00:00:00Z